Cesca Therapeutics (KOOL) Tops Q2 EPS by 5c

Cesca Therapeutics (NASDAQ: KOOL) reported Q2 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $3.29 million versus the consensus estimate of $4.32 million.

For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• Hitachi Ltd. (HIT) Misses Q2 EPS by 7c